Sarah J. Parsons

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Cell Biology, Anatomy Biology
Google:
"Sarah Parsons"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Duska LR, Petroni GR, Lothamer H, et al. (2018) A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer. Cancer Chemotherapy and Pharmacology
Manukyan A, Sargsyan L, Parsons SJ, et al. (2018) P190RhoGAP prevents mitotic spindle fragmentation and is required to activate Aurora A kinase at acentriolar poles. Chromosoma
Portillo JC, Muniz-Feliciano L, Lopez Corcino Y, et al. (2017) Toxoplasma gondii induces FAK-Src-STAT3 signaling during infection of host cells that prevents parasite targeting by autophagy. Plos Pathogens. 13: e1006671
Duska LR, Lothamer H, Faust W, et al. (2016) A phase 0 pharmacodynamic study of dasatinib in women with newly diagnosed endometrial cancer. Journal of Clinical Oncology. 34: e23207-e23207
Sarkar S, Brautigan DL, Parsons SJ, et al. (2014) Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells. Oncogene. 33: 26-33
DaSilva JO, Amorino GP, Casarez EV, et al. (2013) Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling. The Prostate. 73: 801-12
Miyake T, Parsons SJ. (2012) Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation Oncogene. 31: 1431-1441
Skalski M, Slack-Davis J, Parsons SJ. (2012) Abstract 1202: A role for adhesion in epidermal growth factor receptor (EGFR)-mitochondrial translocation Cancer Research. 72: 1202-1202
Valerie NC, Casarez EV, Dasilva JO, et al. (2011) Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation. Cancer Research. 71: 6817-26
Ludwig K, Parsons SJ. (2011) The Tumor Suppressor, p190RhoGAP, Differentially Initiates Apoptosis and Confers Docetaxel Sensitivity to Breast Cancer Cells. Genes & Cancer. 2: 20-30
See more...